JENNIFER LINDSEY: Open Payments
NPI 1316019748 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,098 in 172 payments from 26 companies in 2025. Trend: 2023 $1,227 · 2024 $1,716 · 2025 $3,098
Food & beverage: $2,998Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 49 | $531 |
| Janssen Biotech, Inc. | 13 | $355 |
| E.R. Squibb & Sons, L.L.C. | 15 | $348 |
| ABBVIE INC. | 20 | $339 |
| PFIZER INC. | 10 | $263 |
| UCB, Inc. | 17 | $253 |
| Novartis Pharmaceuticals Corporation | 11 | $252 |
| AstraZeneca Pharmaceuticals LP | 7 | $166 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Sandoz Inc. | 4 | $74 |
Products named: ORENCIA, TREMFYA, RINVOQ, Bimzelx, COSENTYX, KRYSTEXXA, SAPHNELO, ENBREL.
Industry payments across IN — which companies pay providers there.
